Walleye Trading’s HUMANIGEN, INC. HGEN Stock Holding History

Walleye Trading’s Portfolio HGEN Stock Details HGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-7,300	Closed	-$43K	–	6069
2021 Q3	$43K	Buy	+7,300	New	+$103K	﹤0.01%	4681

Other funds holding HGEN

VCM

Valiant Capital Management San Francisco, California $1.74B AUM 64.05% 1-Year Est. Return

Murchinson Toronto, Ontario, Canada $791M AUM 68.08% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

CAC

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Walleye Trading's HGEN Position: Q1 2022 in Review

Walleye Trading sold out of HUMANIGEN, INC. (HGEN) in Q1 2022, closing a stake of 17,400 shares — an estimated $65K sold.

Walleye Trading first reported a position in HGEN in Q3 2021 and held it in 2 quarters. The position peaked at $146K in Q3 2021. 83 funds tracked by Wall St. Rank hold HGEN as of Q1 2022.

Walleye Trading reported no remaining HUMANIGEN, INC. position as of Q1 2022 after selling out during the quarter.
Walleye Trading sold 17,400 HUMANIGEN, INC. shares in Q1 2022, an estimated $65K.
Walleye Trading first reported a position in HUMANIGEN, INC. in Q3 2021 and held it in 2 quarters.
Walleye Trading's HUMANIGEN, INC. position peaked at $146K in Q3 2021.
83 funds tracked by Wall St. Rank held HUMANIGEN, INC. as of Q1 2022.

Based on Walleye Trading's 13F filing for Q1 2022, filed 16 May 2022.